Back to Search Start Over

Two high-fidelity variants: efSaCas9 and SaCas9-HF, which one is better?

Authors :
Lv, Jineng
Xi, Haitao
Lv, Xiujuan
Zhou, Yue
Wang, Jiahua
Chen, Haoran
Yan, Tong
Jin, Jiang
Zhao, Junzhao
Gu, Feng
Song, Zongming
Source :
Gene Therapy; August 2022, Vol. 29 Issue: 7-8 p458-463, 6p
Publication Year :
2022

Abstract

CRISPR/Cas9 (Clustered Regularly Interspaced Short Palindromic Repeats/CRISPR-associated endonuclease Cas9) nucleases have been widely applied for genome engineering. Staphylococcus aureus Cas9 (SaCas9) is compact, which can be packaged in AAV (adeno-associated virus) vector for in vivo gene editing. While, wild-type SaCas9 can induce unwanted off-target mutations and substantially limits the applications. So far, there are two reported SaCas9 variants with high-fidelity, including efSaCas9 from our previous study and SaCas9-HF. However, it remains unknown which one possessing the better fidelity and higher activity. Here, we performed a parallel comparison of efSaCas9 and SaCas9-HF in human cells through fluorescent reporter system and target deep sequencing, respectively. The results demonstrated that efSaCas9 possesses higher cleavage activity and fidelity than SaCas9-HF at the most endogenous sites in human cells. Collectively, our study provides insights for the rational selection of suitable SaCas9 for human genome editing.

Details

Language :
English
ISSN :
09697128 and 14765462
Volume :
29
Issue :
7-8
Database :
Supplemental Index
Journal :
Gene Therapy
Publication Type :
Periodical
Accession number :
ejs58797837
Full Text :
https://doi.org/10.1038/s41434-022-00319-4